Conditions: ALS
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 384
Healthy volunteers: no

Brief summary:
To evaluate and compare the efficacy of two dosing regimens of oral edaravone in subjects with amyotrophic lateral sclerosis (ALS) based on the change in ALS Functional Rating Scale- Revised (ALSFRS-R) score from baseline up to Week 48:

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: MT-1186 intervention 2: Placebo
Intervention descriptions: intervention 1: Oral edaravone intervention 2: Oral

Protocol document:
Prot_000.pdf: 















































































































































































































SAP_001.pdf: